|
?:authorAffiliation
|
-
[\'Research and Development Department, MedGenome Inc, Foster City, CA, USA.\', \'Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.\', \'Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.\', \'MedGenome Labs Ltd., Bangalore, Karnataka, India.\', \'Department of Molecular Genetics, and the Terrence Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada.\', \'ModMab Therapeutics, Foster City, CA, USA.\', \'ModMab Therapeutics, Accelerator for Donnelly Collaboration, University of Toronto, Toronto, ON, Canada.\', \'Wellcome Sanger Institute, Cambridge, UK.\', \'Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.\', \'Midwestern University, Glendale, AZ, USA.\', \'Department of Molecular Biology, SciGenom Labs Pvt Ltd, Kochi, Kerala, India.\', \'AgriGenome Labs Private Ltd, Kochi, Kerala, India.\', \'Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore, Singapore.\', \'Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA. natalia.jura@ucsf.edu.\', \'Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA. natalia.jura@ucsf.edu.\', \'ModMab Therapeutics, Foster City, CA, USA. sekar@sgrf.org.\', \'SciGenom Research Foundation, Bangalore, Karnataka, India. sekar@sgrf.org.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}